HHS Secretary Azar Likely To Advance Medicare Drug Pricing Policies

 
• By Cathy Kelly
Alex Azar, Trump’s HHS secretary nominee, who spoke at the Senate HELP committee 11/29/17
Alex Azar testifies at his confirmation hearing before the Senate HELP Committee on Nov. 29, 2017.

More from Pricing Debate

More from Market Access